HOME Top Market Reports Medical Bionic Implant /Artificial Organs Market - (Vision Bionics/Bionic Eye, Brain Bionics, Heart Bionics/Artificial Heart, Orthopedic Bionics and Ear Bionics) – Trends and Global Forecasts to 2017

Medical Bionic Implant /Artificial Organs Market - (Vision Bionics/Bionic Eye, Brain Bionics, Heart Bionics/Artificial Heart, Orthopedic Bionics and Ear Bionics) – Trends and Global Forecasts to 2017

By: marketsandmarkets.com
Publishing Date: November 2012
Report Code: MD 1368

Discount on Reports  

  Speak to Analyst Enquiry Before Buying
 
purchase report
download pdf  request for customisation


Bionics is mechanical/electronic replacement or enhancement of organs/parts of living organisms. The medical bionic implant/artificial organs market is a potentially growing one with a global market of $12.67 billion in 2012. It is expected to grow at a CAGR of 7.1% to reach $17.82 billion in 2017.

The global artificial organs market has been segmented as vision bionics, ear bionics, orthopedic bionics, heart bionics, and neural/brain bionics. Heart bionics accounts for the largest share in this market, primarily due to a large global population with heart diseases. Rising healthcare expenditure and emergence of new healthcare facilities in emerging economies provides growth opportunities for the medical bionic implants market. The market for certain bionic devices such as exoskeletons, bionic orthopedics, and the bionic eye are skewed in favor of certain regions because of stronger research in these regions as compared to others. In this report, we are also focusing on bionic devices in pipeline, which include wearable artificial kidney, bio-lung, and artificial pancreas.

New and improved technologies, increasing organ failure owing to aging and age-related disorders, increasing accidents and injuries leading to amputations, and rise in number of people awaiting organ transplants are the major drivers slated to propel the growth of this market. However, a few pivotal factors restraining the growth of this market are high cost of devices and uncertain reimbursement scenarios in different regions, limited surgical expertise, and high cost of development. The opportunities in this market for new entrants include improving income levels, and rising awareness in emerging economies.

North America dominates the artificial organs market in 2012, followed by Europe. However, the adoption of novel medical bionics as a therapy in emerging markets is gaining momentum at a fast pace due to a growing population and increasing awareness among patients and players. In addition, increasing healthcare expenditure, growing income levels, rising preference for bionics due to better and efficient recovery as compared to prosthetics, growing surgical procedures in lieu with medical tourism, and lesser competition than mature countries, have amplified the interest of market players in emerging markets.

The key players in this market are Orthofix International N.V. (The Netherlands), Biomet, Inc. (U.S.), Medtronic, Inc. (U.S.), Cochlear Ltd. (Australia), Second Sight Medical Products, Inc. (U.S.), Ossur (Iceland), Ekso Bionics (U.S.), and St. Jude Medical, Inc. (U.S.).

Scope of the Report

This research report categorizes the global medical bionic implants market on the basis of products, technologies, and type of fixation. These markets are broken down into segments and sub-segments, providing value analysis for 2010, 2011, and 2012, as well as forecast up to 2017. Each market is comprehensively analyzed by geography (North America, Europe, Asia-Pacific, and Rest of the World) to provide in-depth information on the global scenario.

Global Medical Bionics Market, By Products
Vision Bionics 

    • Bionic Eye              

Ear Bionics    

    • Cochlear Implant 
    • Bone Anchored Hearing Aid (Baha)      

Orthopedic Bionics    

    • Bionic Limb        
    • Bionic Hand        
    • Bionic Leg
      • Bionic Knee   
      • Bionic Feet    
    • Bionic Finger
    • Exoskeleton       
    • Electrical Bone Growth Stimulators      
      • Invasive Bone Growth Stimulators  
      • Non-Invasive Bone Growth Stimulators     

Heart Bionics 

    • Pacemaker
      • Implantable Cardiac Pacemaker
      • External Pacemaker 
    • Total Artificial Heart      
    • Ventricular Assist Device
    • Artificial Heart Valves    
      • Mechanical Heart Valves
      • Tissue Heart Valves

Neural /Brain Bionics

  • Deep Brain Stimulator   
  • Vagus Nerve Stimulator 
  • Spinal Cord Stimulator   

Global Medical Bionics Market, By Technology

  • Mechanical
  • Electronic

Global Medical Bionics Market, By Method of Fixation

  • Implantable
  • Externally Worn

Medical Bionics Market, By Geography

  • North America
  • Europe
  • Asia-Pacific
  • RoW

TABLE OF CONTENTS
 
1 INTRODUCTION
   1.1 KEY TAKE AWAYS
   1.2 REPORT DESCRIPTION
   1.3 MARKETS COVERED
   1.4 STAKEHOLDERS
   1.5 RESEARCH METHODOLOGY
         1.5.1 MARKET SIZE
         1.5.2 MARKET SHARE
         1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
         1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES
         1.5.5 ASSUMPTIONS

2 EXECUTIVE SUMMARY

3 MARKET OVERVIEW
   3.1 INTRODUCTION
   3.2 EVOLUTION
   3.3 MARKET SEGMENTATION
   3.4 BIONICS & PROSTHESES: SIMILARITIES & DIFFERENCES
   3.5 MARKET DYNAMICS
         3.5.1 DRIVERS
                  3.5.1.1 TECHNOLOGICAL ADVANCEMENTS
                  3.5.1.2 INCREASING ORGAN FAILURE OWING TO AGING & AGE-RELATED DISORDERS
                  3.5.1.3 INCREASING ACCIDENTS & INJURIES LEADING TO AMPUTATIONS.
                  3.5.1.4 RISE IN NUMBER OF PEOPLE AWAITING ORGAN TRANSPLANTS
         3.5.2 RESTRAINTS
                  3.5.2.1 HIGH COST OF DEVICES AND UNCERTAIN REIMBURSEMENT
                              SCENARIOS IN DIFFERENT REGIONS
                  3.5.2.2 LIMITED SURGICAL EXPERTISE
                  3.5.2.3 HIGH COST OF DEVELOPMENT
         3.5.3 OPPORTUNITIES
                  3.5.3.1 ADVANTAGEOUS IN COMPARISON PROSTHETICS
                  3.5.3.2 IMPROVING INCOME LEVELS & RISING AWARENESS COULD
                              PUSH DEMAND IN EMERGING ECONOMIES
   3.6 MARKET SHARE ANALYSIS
         3.6.1 EAR BIONICS MARKET
         3.6.2 ORTHOPEDIC BIONICS IMPLANT/ARTIFICIAL ORGANS MARKET
         3.6.3 HEART BIONICS IMPLANT/ARTIFICIAL ORGANS MARKET
         3.6.4 BRAIN/NEURAL BIONICS MARKET
   3.7 EMERGING TECHNOLOGIES
         3.7.1 BIONICS IMPLANT/ARTIFICIAL ORGANS IN THE PIPELINE
                  3.7.1.1 ARTIFICIAL PANCREAS
                  3.7.1.2 BIO-LUNG
                  3.7.1.3 WEARABLE ARTIFICIAL KIDNEY

4 GLOBAL MEDICAL BIONIC IMPLANT/ARTIFICIAL ORGANS MARKET, BY PRODUCTS
   4.1 INTRODUCTION
   4.2 VISION BIONICS
         4.2.1 BIONIC EYE
   4.3 EAR BIONICS
         4.3.1 COCHLEAR IMPLANT
         4.3.2 BONE ANCHORED HEARING AID (BAHA)
   4.4 ORTHOPEDIC BIONICS
         4.4.1 BIONIC LIMB
                  4.4.1.1 BIONIC HAND
                  4.4.1.2 BIONIC LEG
                              4.4.1.2.1 BIONIC KNEE
                              4.4.1.2.2 BIONIC FEET
         4.4.2 BIONIC FINGER
         4.4.3 EXOSKELETON
         4.4.4 ELECTRICAL BONE GROWTH STIMULATORS
                  4.4.4.1 INVASIVE BONE GROWTH STIMULATORS
                  4.4.4.2 NON-INVASIVE BONE GROWTH STIMULATORS
   4.5 HEART BIONICS
         4.5.1 PACEMAKER
                  4.5.1.1 IMPLANTABLE CARDIAC PACEMAKER
                  4.5.1.2 EXTERNAL PACEMAKER
         4.5.2 TOTAL ARTIFICIAL HEART
         4.5.3 VENTRICULAR ASSIST DEVICE
         4.5.4 ARTIFICIAL HEART VALVE
                  4.5.4.1 MECHANICAL HEART VALVE
                  4.5.4.2 TISSUE HEART VALVE
   4.6 NEURAL/BRAIN BIONICS
                  4.6.1.1 DEEP BRAIN STIMULATOR
                  4.6.1.2 VAGUS NERVE STIMULATOR
                  4.6.1.3 SPINAL CORD STIMULATOR

5 GLOBAL MEDICAL BIONIC IMPLANT/ARTIFICIAL ORGANS MARKET, BY TECHNOLOGY
   5.1 INTRODUCTION
   5.2 ELECTRONIC BIONICS
   5.3 MECHANICAL

6 GLOBAL MEDICAL BIONIC IMPLANT/ARTIFICIAL ORGANS MARKET, BY TYPE OF FIXATION
   6.1 INTRODUCTION
   6.2 EXTERNALLY WORN
   6.3 IMPLANTABLE

7 GEOGRAPHIC ANALYSIS
   7.1 INTRODUCTION
   7.2 NORTH AMERICA
   7.3 EUROPE
   7.4 ASIA- PACIFIC
   7.5 ROW

8 COMPETITIVE LANDSCAPE
   8.1 INTRODUCTION
   8.2 MERGERS & ACQUISITIONS
   8.3 AGREEMENTS, PARTNERSHIPS & COLLABORATIONS
   8.4 NEW PRODUCT LAUNCH
   8.5 APPROVALS
   8.6 EXPANSION
   8.7 OTHER DEVELOPMENTS

9 COMPANY PROFILES (Overview, Financials, Products & Services, Strategy, And Developments)*
   9.1 ABIOMED, INC.
   9.2 BERLIN HEART GMBH
   9.3 BIOMET, INC.
   9.4 BOSTON SCIENTIFIC CORPORATION
   9.5 COCHLEAR, LTD.
   9.6 EDWARDS LIFESCIENCES CORPORATION
   9.7 EKSO BIONICS
   9.8 HEARTWARE INTERNATIONAL, INC.
   9.9 IWALK, INC.
   9.10 JARVIK HEART, INC.
   9.11 LIFENET HEALTH
   9.12 MED-EL ELEKTROMEDIZINISCHE GERΔTE G.M.B.H.
   9.13 MEDTRONIC, INC.
   9.14 NANO RETINA, INC.
   9.15 ORTHOFIX INTERNATIONAL N.V.
   9.16 OSSUR
   9.17 OTTO BOCK HEALTHCARE GMBH.
   9.18 SECOND SIGHT MEDICAL PRODUCTS, INC.
   9.19 SONOVA HOLDING AG
   9.20 ST. JUDE MEDICAL, INC.
   9.21 SORIN S.P.A.
   9.22 TERUMO CORPORATION
   9.23 THORATEC CORPORATION
   9.24 TIBION CORPORATION
   9.25 TOUCH BIONICS, LTD.
*Details On Financials, Product & Services, Strategy, And Developments Might Not Be Captured In Case Of Unlisted Companies.

LIST OF TABLES
   
TABLE 1 GLOBAL ARTIFICIAL ORGANS MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 2 MEDICAL BIONIC IMPLANT/ARTIFICIAL ORGANS MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 3 VISION BIONICS MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 4 GLOBAL EAR BIONICS MARKET, BY PRODUCTS,
2010 – 2017 ($MILLION)
TABLE 5 EAR BIONICS MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 6 COCHLEAR IMPLANT MARKET, BY GEOGRAPHY,
2010 – 2017 ($MILLION)
TABLE 7 BONE ANCHORED HEARING AID (BAHA) MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 8 GLOBAL ORTHOPEDIC BIONICS IMPLANT (ARTIFICIAL ORGANS) MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 9 ORTHOPEDIC BIONICS IMPLANT/ARTIFICIAL ORGANS MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 10 GLOBAL BIONIC LIMB MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 11 BIONIC LIMB MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 12 BIONIC HAND MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 13 GLOBAL BIONIC LEG MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 14 BIONIC LEG MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 15 BIONIC KNEE MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 16 BIONIC FEET MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 17 BIONIC FINGER MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 18 EXOSKELETON MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 19 GLOBAL ELECTRICAL BONE GROWTH STIMULATORS MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 20 ELECTRICAL BONE GROWTH STIMULATORS MARKET, BY GEOGRAPHY, 2010 – 2017  ($MILLION)
TABLE 21 INVASIVE ELECTRICAL BONE GROWTH STIMULATORS MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 22 NON-INVASIVE ELECTRICAL BONE GROWTH STIMULATORS MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 23 GLOBAL HEART BIONIC IMPLANT/ARTIFICIAL ORGANS MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 24 HEART BIONIC IMPLANT/ARTIFICIAL ORGANS MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 25 GLOBAL PACEMAKER MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 26 PACEMAKER MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 27 TOTAL ARTIFICIAL HEART MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 28 VENTRICULAR ASSIST DEVICES MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 29 GLOBAL ARTIFICIAL HEART VALVE MARKET, BY PRODUCT TYPE, 2010 – 2017 ($MILLION)
TABLE 30 ARTIFICIAL HEART VALVE MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 31 MECHANICAL HEART VALVE MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 32 TISSUE HEART VALVE MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 33 GLOBAL NEURAL/BRAIN BIONICS MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 34 NEURAL/BRAIN BIONICS MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 35 DEEP BRAIN STIMULATOR MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 36 VAGUS NERVE STIMULATOR MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 37 SPINAL CORD STIMULATOR MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 38 GLOBAL ARTIFICIAL ORGANS MARKET, BY TECHNOLOGY, 2010 – 2017 ($MILLION)
TABLE 39 GLOBAL MEDICAL BIONIC IMPLANT (ARTIFICIAL ORGANS) MARKET, BY TYPE OF FIXATION, 2010 – 2017 ($MILLION)
TABLE 40 NORTH AMERICA: ARTIFICIAL ORGANS MARKET, BY  PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 41 NORTH AMERICA: EAR BIONICS MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 42 NORTH AMERICA: ORTHOPEDIC BIONIC IMPLANT(ARTIFICIAL ORGANS) MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 43 NORTH AMERICA: BIONIC LIMB MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 44 NORTH AMERICA: BIONIC LEG MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 45 NORTH AMERICA: ELECTRICAL BONE GROWTH STIMULATOR MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 46 NORTH AMERICA: ARTIFICIAL ORGANS MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 47 NORTH AMERICA: ARTIFICIAL HEART VALVE MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 48 NORTH AMERICA: NEURAL/BRAIN BIONICS MARKET, BY PRODUCTS,2010 – 2017 ($MILLION)
TABLE 49 EUROPE: MEDICAL BIONIC IMPLANT/ARTIFICIAL ORGANS MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 50 EUROPE: EAR BIONICS MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 51 EUROPE: ORTHOPEDIC BIONICS IMPLANT/ARTIFICIAL ORGANS MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 52 EUROPE: BIONIC LIMB MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 53 EUROPE: BIONIC LEG MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 54 EUROPE: ELECTRICAL BONE GROWTH STIMULATOR MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 55 EUROPE: HEART BIONICS IMPLANT/ARTIFICIAL ORGANS MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 56 EUROPE: ARTIFICAL HEART VALVE MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 57 EUROPE: NEURAL/BRAIN BIONICS MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 58 ASIA-PACIFIC: ARTIFICIAL ORGANS MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 59 ASIA-PACIFIC: EAR BIONICS MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 60 ASIA-PACIFIC: ORTHOPEDIC BIONICS IMPLANT/ARTIFICIAL ORGANS MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 61 ASIA-PACIFIC: BIONIC LIMB MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 62 ASIA-PACIFIC: BIONIC LEG MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 63 ASIA-PACIFIC: ELECTRICAL BONE GROWTH STIMULATOR MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 64 ASIA-PACIFIC: HEART BIONICS IMPLANT/ARTIFICIAL ORGANS MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 65 ASIA-PACIFIC: ARTIFICIAL HEART VALVE MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 66 ASIA-PACIFIC: NEURAL/BRAIN BIONICS MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 67 ROW: ARTIFICIAL ORGANS MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 68 ROW: EAR BIONICS MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 69 ROW: ORTHOPEDIC BIONICS IMPLANT(ARTIFICIAL ORGANS) MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 70 ROW: BIONIC LIMB MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 71 ROW: BIONIC LEG MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 72 ROW: ELECTRICAL BONE GROWTH STIMULATOR MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 73 ROW: HEART BIONICS IMPLANT/ARTIFICIAL ORGANS MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 74 ROW: ARTIFICAL HEART VALVE MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 75 ROW: NEURAL/BRAIN BIONICS MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 76 MERGERS & ACQUISITIONS, 2010 –2012 TABLE 77 AGREEMENTS, PARTNERSHIPS & COLLABORATIONS, 2010 –2012
TABLE 78 NEW PRODUCT LAUNCH, 2010 –2012
TABLE 79 APPROVALS, 2010 –2012
TABLE 80 EXPANSION, 2010 – 2012
TABLE 81 OTHER DEVELOPMENTS, 2010 – 2012
TABLE 82 ABIOMED, INC.: TOTAL REVENUE AND R&D EXPENDITURE, 2010 – 2012 ($MILLION)
TABLE 83 ABIOMED, INC.: TOTAL REVENUE, BY SEGMENTS, 2010 – 2012 ($MILLION)
TABLE 84 ABIOMED, INC.: TOTAL REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 85 BIOMET, INC.: TOTAL REVENUE AND R&D EXPENDITURE, 2010 – 2012 ($MILLION)
TABLE 86 BIOMET, INC.: TOTAL REVENUE, BY SEGMENTS, 2010 – 2012 ($MILLION)
TABLE 87 BIOMET, INC.: TOTAL REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 88 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011 ($MILLION)
TABLE 89 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 90 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 91 COCHLEAR, LTD.: TOTAL REVENUE AND R&D EXPENDITURE, 2010 – 2012 ($MILLION)
TABLE 92 COCHLEAR, LTD.: TOTAL REVENUE, BY SEGMENTS, 2010 – 2012 ($MILLION)
TABLE 93 COCHLEAR, LTD.: TOTAL REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 94 EDWARDS LIFESCIENCES CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE 2009 – 2011 ($MILLION)
TABLE 95 EDWARDS LIFESCIENCES CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 96 EDWARDS LIFESCIENCES CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 97 HEARTWARE INTERNATIONAL, INC.: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011 ($MILLION)
TABLE 98 HEARTWARE INTERNATIONAL, INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 99 MEDTRONIC, INC.: TOTAL REVENUE AND R&D EXPENDITURE, 2010 – 2012 ($MILLION)
TABLE 100 MEDTRONIC, INC.: TOTAL REVENUE, BY SEGMENTS, 2010 - 2012 ($MILLION)
TABLE 101 MEDTRONIC, INC.: CARDIAC AND VASCULAR GROUP REVENUE, BY SEGMENTS, 2010 – 2012 ($MILLION)
TABLE 102 MEDTRONIC, INC.: RESTORATIVE THERAPIES GROUP REVENUE, BY SEGMENTS, 2010 – 2012 ($MILLION)
TABLE 103 MEDTRONIC, INC.: TOTAL REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 104 ORTHOFIX INTERNATIONAL N V: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011 ($MILLION)
TABLE 105 ORTHOFIX INTERNATIONAL N V: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 106 ORTHOFIX INTERNATIONAL N V: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 107 OSSUR HF: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011 ($MILLION)
TABLE 108 OSSUR HF: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 109 OSSUR HF: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 110 OTTO BOCK HEALTHCARE GMBH: TOTAL REVENUE, 2009 – 2011 ($MILLION)
TABLE 111 OTTO BOCK HEALTHCARE GMBH. TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 112 OTTO BOCK HEALTHCARE GMBH: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 113 SONOVA HOLDING AG: TOTAL REVENUE AND R&D EXPENDITURE, 2010 – 2012 ($MILLION)
TABLE 114 SONOVA HOLDING AG: TOTAL REVENUE, BY SEGMENTS, 2010 – 2012 ($MILLION)
TABLE 115 SONOVA HOLDING AG: TOTAL REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 116 ST. JUDE MEDICAL, INC.: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011 ($MILLION)
TABLE 117 ST. JUDE MEDICAL, INC.: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 118 ST. JUDE MEDICAL, INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 119 SORIN S.P.A.: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011 ($MILLION)
TABLE 120 SORIN S.P.A.: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 121 SORIN S.P.A.: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 122 TERUMO CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE, 2010 – 2012 ($MILLION)
TABLE 123 TERUMO CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2010 – 2012 ($MILLION)
TABLE 124 TERUMO CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 125 THORATEC CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011 ($MILLION)
TABLE 126 THORATEC CORPORATION: TOTAL REVENUE, BY PRODUCTS LINES, 2009 – 2011 ($MILLION)
TABLE 127 THORATEC CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)

LIST OF FIGURES
 
FIGURE 1 GLOBAL MEDICAL BIONIC IMPLANTS MARKET, BY PRODUCTS, 2010 – 2017 ($MILLION)
FIGURE 2 GLOBAL ARTIFICIAL ORGANS MARKET, BY SEGMENTS
FIGURE 3 GLOBAL ARTIFICIAL ORGANS MARKET, BY PRODUCTS
FIGURE 4 ARTIFICIAL ORGANS MARKET SHARE ANALYSIS, BY REVENUE, 2011
FIGURE 5 EAR BIONICS MARKET SHARE ANALYSIS, BY REVENUE, 2011
FIGURE 6 ORTHOPEDIC BIONICS IMPLANT/ARTIFICIAL ORGANS MARKET SHARE ANALYSIS, BY REVENUE, 2011
FIGURE 7 HEART BIONICS IMPLANT/ARTIFICIAL ORGANS MARKET SHARE ANALYSIS, BY REVENUE, 2011
FIGURE 8 BRAIN/NEURAL BIONICS MARKET SHARE ANALYSIS, BY REVENUE, 2011
FIGURE 9 CLASSIFICATION OF ORTHOPEDIC BIONICS
FIGURE 10 CLASSIFICATION OF BIONIC LIMBS
FIGURE 11 CLASSIFICATION OF ELECTRICAL BONE GROWTH STIMULATORS
FIGURE 12 GLOBAL MEDICAL BIONIC IMPLANT /ARTIFICIAL ORGANS MARKET, BY TECHNOLOGY
FIGURE 13 GLOBAL ARTIFICIAL ORGANS MARKET, BY TYPE OF FIXATION
FIGURE 14 KEY GROWTH STRATEGIES, 2010 – 2012 

The term ‘bionics’ is analogous to the term ‘biomimetics’, which involves the study and development of artificial systems that replicate or mimic the functioning of natural biological systems. The science of bionics deals with the application of naturally found biological systems to the study and development of artificially engineered systems. The motive behind developing these artificial systems is to replace and enhance existing natural systems, which may malfunction or fail to function in a desired manner using either mechanical or electronic modalities. The medical bionic implants market is a potentially growing one with a global market of $12.67 million in 2012. It is expected to grow at a CAGR of 7.1% to reach $17.82 billion in 2017.

The global medical bionic implants/artificial organs market has been segmented as vision bionics, ear bionics, orthopedic bionics, heart bionics, and neural/brain bionics. Vision bionics consists of the bionic eye; ear bionics includes cochlear implants and BAHA; orthopedic bionics includes bionic limb, bionic finger, exoskeleton and electrical bone growth stimulators; heart bionics comprises of pacemakers, TAH, ventricular assist devices, and artificial heart valves; and neural/brain bionics consists of deep brain stimulator, vagus nerve stimulator, and spinal cord stimulator. Based on technology, medical bionic implants are divided into two groups - mechanical bionics and electronic bionics. In addition, depending upon the type of fixation, they are classified as externally worn and implantable.

The artificial organs industry is under dramatic transformation globally and will witness significant changes in the coming years, primarily driven by innovation, globalization, and commoditization of products. Amputation, for instance, was considered equivalent to failure to salvage a limb; however, with the presence of advanced powered prosthetics, it is no more considered so. With the advent of bionic technology, amputees have access to limb replacements and enhancement. Orthopedic bionics is more scientifically advanced than prosthetics because it contains specific sensors that can sense and predict user action, based on his/her environment.

Technological innovations in the medical bionic implants industry have been witnessed in the past few years. Newer products with better safety and efficacy contribute to the widespread adoption of medical bionics by physicians worldwide. However, a few pivotal factors restraining the growth of this market are high cost of devices, uncertain reimbursement scenarios in different regions, limited surgical expertise, and high cost of development.  

The penetration rate of medical bionics in emerging markets is low. However, established companies and new entrants in the medical bionic implants market should consider the GDP growth rates of these countries, ease of product approval, increasing procedural volumes, and low penetration rates compared to mature markets as factors that will drive growth in these regions.

The key players in this market are Orthofix International N.V. (The Netherlands), Biomet, Inc. (U.S.), Medtronic, Inc. (U.S.), Cochlear, Ltd. (Australia), Second Sight Medical Products, Inc. (U.S.), Ossur (Iceland), Ekso Bionics (U.S.), and St. Jude Medical, Inc. (U.S.).


GLOBAL MEDICAL BIONICS IMPLANT /ARTIFICIAL ORGANS MARKET SHARE, BY PRODUCTS, 2017

Medical Bionic Implants Market

Source: Annual Reports, SEC Filings, Press Releases, Expert Interviews, MnM Analysis

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports